A Phase I Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004

Trial Identifier:	D7260C00006
Sponsor:	AstraZeneca
Start Date:	December 2024
Primary Completion Date:	April 2025
Study Completion Date:	April 2025
Condition:	Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, FL	Miami Lakes, FL, US, 33014
US, FL	Orlando, FL, US, 32809
US, FL	Orlando, FL, US, 32808

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.